{"FP": [{"generated": ["patient"], "gold": [], "text": "Progressive mobilization of the patient was obtained as well as a complete normalization of the laboratory findings."}, {"generated": ["he"], "gold": [], "text": "In May 2009 he underwent surgical removal of the abdominal mass achieving a complete margin negative (R0) resection."}, {"generated": ["lesion"], "gold": [], "text": "In spite of chemotherapy, the lesion progressed rapidly reaching 16 \u00d7 10 cm and extending into the pre-aortic seat of the retro-peritoneum space."}, {"generated": ["patient"], "gold": [], "text": "Due to the absence of co-morbidity, the patient had not received any other drugs during treatment with trabectedin."}, {"generated": ["cancer patients"], "gold": [], "text": "As known, cancer patients are likely to experience drug interactions due to the increased number and types of chemotherapeutic drugs, their combinations in oncology practice and their narrow therapeutic index, the achievement of a prolonged life expectancy, and the common use of a broad range of ancillary medications to prevent and/or treat cancer-related syndromes and treatment-induced toxicity [8]."}, {"generated": ["patient"], "gold": [], "text": "It was discovered that the patient took cannabis for chronic back pain, and a pharmacogenomics (PGx) test indicated the presence of variants for the COMT and HTR2A genes."}, {"generated": ["clinical pharmacist"], "gold": [], "text": "The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1)."}, {"generated": ["his PCP"], "gold": [], "text": "However, his PCP determined that additional medication for pain control was warranted."}, {"generated": ["past two decades"], "gold": [], "text": "During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment."}, {"generated": ["93.4% of cancer patients"], "gold": [], "text": "In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4]."}, {"generated": ["South Korean population"], "gold": [], "text": "In South Korean population reported a range from 29% to 83% [5]."}, {"generated": ["an increasing number of studies"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["pharmacogenomics studies", "clinic study"], "gold": [], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": ["pharmacogenomics studies", "clinic study"], "gold": [], "text": "In the following, we reviewed pharmacogenomics studies, mainly from clinic study, on some important herb products that have been reported to have HDIs."}, {"generated": ["conventional therapeutic drugs", "herbal remedies"], "gold": [], "text": "With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2]."}, {"generated": ["conventional therapeutic drugs", "herbal remedies"], "gold": [], "text": "With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2]."}, {"generated": ["researchers"], "gold": [], "text": "With the tremendous surge in the acceptance of and public interest in herbal medicinal remedies, researchers are adopting the guidelines and opinions proposed for DDI studies to study HDI."}, {"generated": ["patients", "consumers"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["patients", "consumers"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["Fourteen subjects"], "gold": [], "text": "[44]."}, {"generated": ["Serial dilutions of the extracts", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm \u00d7 100 mm, 1.7 \u00b5m particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe."}, {"generated": ["Serial dilutions of the extracts", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Briefly, serial dilutions of the extracts were added to a mixture of regeneration system, NADP Phytofingerprinting was performed on the extracts using a Waters Acquity UPLC system (Waters Corporation, Milford, MA, USA) with an Acquity BEH C18 column (2.1 mm \u00d7 100 mm, 1.7 \u00b5m particle size) incorporating a binary pump, vacuum degasser, autosampler, column oven, and Micromass Xevo tandem quadrupole mass spectrometric detector (QTOF xevo G2; Waters micromass, Manchester, UK) equipped with ESI probe."}, {"generated": ["31% of diabetic patients"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["50 \u03bcl", "20 \u03bcl 2.5 \u00d7 HotMasterMix", "primer pairs (0.25 \u03bcM)", "250 ng human genomic DNA", "PCR"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["50 \u03bcl", "20 \u03bcl 2.5 \u00d7 HotMasterMix", "primer pairs (0.25 \u03bcM)", "250 ng human genomic DNA", "PCR"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["50 \u03bcl", "20 \u03bcl 2.5 \u00d7 HotMasterMix", "primer pairs (0.25 \u03bcM)", "250 ng human genomic DNA", "PCR"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["50 \u03bcl", "20 \u03bcl 2.5 \u00d7 HotMasterMix", "primer pairs (0.25 \u03bcM)", "250 ng human genomic DNA", "PCR"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["50 \u03bcl", "20 \u03bcl 2.5 \u00d7 HotMasterMix", "primer pairs (0.25 \u03bcM)", "250 ng human genomic DNA", "PCR"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["carriers of the CYP2C9*3 allele"], "gold": [], "text": "By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively."}, {"generated": ["Serological titers"], "gold": [], "text": "Serological titers for acute cytomegalovirus (CMV) and Epstein Barr virus (EBV) were negative."}, {"generated": ["she"], "gold": [], "text": "Although she was initially asymptomatic, she developed right upper quadrant abdominal pain, fatigue, and lower extremity edema by the time of her presentation."}, {"generated": ["black cohosh"], "gold": [], "text": "The American College of Obstetrics and Gynecology included black cohosh as a possible remedy for the vasomotor symptoms of menopause [15]."}, {"generated": ["People with diabetes"], "gold": [], "text": "People with diabetes receiving this combination should be closely monitored to evaluate possible signs of reduced efficacy."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["Penicillin-streptomycin", "Sodium Pyruvate", "Minimal Essential Medium (MEM)", "Hanks balanced salt solution (HBSS)", "HEPES", "Trypsin EDTA", "Dulbecco\u2019s Modified Eagle Medium (DMEM)"], "gold": [], "text": "Dulbecco\u2019s Modified Eagle Medium (DMEM), Minimal Essential Medium (MEM), Hanks balanced salt solution (HBSS), HEPES, Trypsin EDTA, Penicillin-streptomycin, and Sodium Pyruvate were from GIBCO BRL (Invitrogen Corp., Grand Island, NY, USA)."}, {"generated": ["12 adult", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["12 adult", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["anti-diabetic", "cardio-protective effects", "anti-obesity"], "gold": [], "text": "The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17]."}, {"generated": ["anti-diabetic", "cardio-protective effects", "anti-obesity"], "gold": [], "text": "The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17]."}, {"generated": ["anti-diabetic", "cardio-protective effects", "anti-obesity"], "gold": [], "text": "The anti-diabetic [9,10], anti-obesity [11], and cardio-protective effects [12,13,14] of rooibos extracts are of specific relevance given the global increase in the prevalence of diabetes and obesity [15,16,17]."}, {"generated": ["IC CYP2C9", "higher levels of polyphenols", "FRE", "ASP"], "gold": [], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["IC CYP2C9", "higher levels of polyphenols", "FRE", "ASP"], "gold": [], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["IC CYP2C9", "higher levels of polyphenols", "FRE", "ASP"], "gold": [], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["IC CYP2C9", "higher levels of polyphenols", "FRE", "ASP"], "gold": [], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["in vitro study"], "gold": [], "text": "Statistical analyses were performed using GraphPad Prism This in vitro study indicated that combining nutraceuticals containing rooibos extracts with drugs metabolized by CYP2C8 and CYP3A4 could potentially alter the pharmacodynamics and safety of these drugs."}, {"generated": ["each patient"], "gold": [], "text": "Statistical analysis  For each patient, the values of AUC0\u2013\u221e, t1/2 and Cmax of docetaxel in cycle 1 (before E. purpurea) were compared with values obtained in cycle 2 (after E. purpurea)."}, {"generated": ["LS180 cells"], "gold": [], "text": "In LS180 cells, our group has shown significant induction of CYP3A4 by isolated alkylamides and E. purpurea extracts using a gene reporter assay, which is a reliable method to assess the CYP3A4 induction potential of compounds [23]."}, {"generated": ["1 mL of ethyl acetate", "100 \u00b5L plasma", "10 \u00b5L ethyl gallate"], "gold": [], "text": "Briefly, 1 mL of ethyl acetate was added to 100 \u00b5L plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 \u00b5L ethyl gallate (1 \u00b5g/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes."}, {"generated": ["1 mL of ethyl acetate", "100 \u00b5L plasma", "10 \u00b5L ethyl gallate"], "gold": [], "text": "Briefly, 1 mL of ethyl acetate was added to 100 \u00b5L plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 \u00b5L ethyl gallate (1 \u00b5g/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes."}, {"generated": ["1 mL of ethyl acetate", "100 \u00b5L plasma", "10 \u00b5L ethyl gallate"], "gold": [], "text": "Briefly, 1 mL of ethyl acetate was added to 100 \u00b5L plasma and ascorbic acid-EDTA solution 10:1 (v/v) mixture with 10 \u00b5L ethyl gallate (1 \u00b5g/mL) as internal standard and vortexed for 15 minutes and centrifuged at 4,500 rpm for 20 minutes."}, {"generated": ["The concentration\u2013time profiles of EC, EGC, ECG, and EGCG"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean \u00b1 SD for continuous variables and as ratios for categorical variables."}, {"generated": ["humans", "animals"], "gold": [], "text": "In particular, the beneficial effects of red ginseng products for reducing the symptoms of rheumatoid arthritis have been proven in animals and humans [24,25,26,27,36]."}, {"generated": ["humans", "animals"], "gold": [], "text": "In particular, the beneficial effects of red ginseng products for reducing the symptoms of rheumatoid arthritis have been proven in animals and humans [24,25,26,27,36]."}, {"generated": ["Rat liver microsomes"], "gold": [], "text": "The maximum plasma concentration (C Rat liver microsomes were used to determine the metabolic rate of AC."}, {"generated": ["effective plasma drug concentration"], "gold": [], "text": "Its effective plasma drug concentration is close to the toxic concentration, and large individual differences in the effects of the drug have been observed."}, {"generated": ["Western drugs"], "gold": [], "text": "Most of these reports and studies are on combinations with Western drugs."}, {"generated": ["Single TCM"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["limited research"], "gold": [], "text": "Although a lot of experience has been accumulated in the clinical application of digoxin over the years, limited research has been conducted on its possible interactions with TCM formulations."}, {"generated": ["Hepatocytes"], "gold": [], "text": "Hepatocytes cultured in this format are responsive to nuclear receptor agonists and maintain important transporter function necessary for proper drug disposition (Yang et al., 2016)."}, {"generated": ["C. asiatica"], "gold": [], "text": "C. asiatica Plant Material and Preparation of CAW-R61J."}, {"generated": ["23.9% from dried CA for CAW-R61H", "21.4% from dried CA for CAW-R61F"], "gold": [], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["23.9% from dried CA for CAW-R61H", "21.4% from dried CA for CAW-R61F"], "gold": [], "text": "Aliquots of the two filtrates were shipped to Oregon Health & Science University (OHSU, Portland, OR), where they were frozen and lyophilized, yielding 21.4% from dried CA for CAW-R61F (extraction lot 1) and 23.9% from dried CA for CAW-R61H (extraction lot 2)."}, {"generated": ["Plates"], "gold": [], "text": "Plates were thawed at ambient temperature."}, {"generated": ["12 adult male Sprague Dawley rats"], "gold": [], "text": "2 above (substituting logEC50 for logIC50)."}, {"generated": ["12 adult male Sprague Dawley rats"], "gold": [], "text": "; data not shown)."}, {"generated": ["Table 8"], "gold": [], "text": "3; Table 8) in a manner consistent with the literature (Ring et al., 1996; Suzuki et al., 2002; Emoto et al., 2003; Walsky et al., 2006; VandenBrink et al., 2011; Zhao et al., 2012; Thu et al., 2017)."}, {"generated": ["unknown inhibitory CAW-R61J compounds"], "gold": [], "text": "Ultimately, the clinical relevance of the weak P450 inhibition seen in this study will depend on the IC50 values of the as yet unknown inhibitory CAW-R61J compounds and their in vivo concentration achieved in humans."}, {"generated": ["Three concentrations of QC samples"], "gold": [], "text": "Three concentrations of quality control (QC) samples were prepared at low, medium, and high concentrations in the range of the standard calibration curves."}, {"generated": ["150 \u03bcL acetonitrile", "50 \u03bcL aliquots", "1 ng/mL berberine"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["150 \u03bcL acetonitrile", "50 \u03bcL aliquots", "1 ng/mL berberine"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["150 \u03bcL acetonitrile", "50 \u03bcL aliquots", "1 ng/mL berberine"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["Figure 2"], "gold": [], "text": "Figure 2 shows the chromatograms of the blank matrix and those of fimasartan, fimasartan-amide, amlodipine, and hydrochlorothiazide spiked at the LLOQ or rat plasma samples 1 h after oral administration of fimasartan, amlodipine, and hydrochlorothiazide."}, {"generated": ["previous published reports", "same MRM condition"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["previous published reports", "same MRM condition"], "gold": [], "text": "We also used the same MRM condition as previously published reports [39,40] and the product ion mass spectra from fimasartan, amlodipine, and hydrochlorothiazide showed different mass fragmentation patterns (Figure 1)."}, {"generated": ["M.P."], "gold": [], "text": "and M.P."}, {"generated": ["people taking ART"], "gold": [], "text": "However, attention has now shifted from reduction in mortality to improvement of the quality of life for people taking ART [1,2]."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["NVP", "EFV"], "gold": [], "text": "EFV and NVP have been associated with a number of side effects including liver damage, nausea, vomiting, fever, diarrhoea, dyslipidemia and headache [10]."}, {"generated": ["developing countries"], "gold": [], "text": "There is substantial evidence supporting the potential of medicinal plants in combating diseases, especially in developing countries [12,13,14,15]."}, {"generated": ["Michelle Skelton", "Dee Blackhurst", "Kevin Dzobo", "Ambroise Wonkam", "Denis Chopera"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["Michelle Skelton", "Dee Blackhurst", "Kevin Dzobo", "Ambroise Wonkam", "Denis Chopera"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["Michelle Skelton", "Dee Blackhurst", "Kevin Dzobo", "Ambroise Wonkam", "Denis Chopera"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["Michelle Skelton", "Dee Blackhurst", "Kevin Dzobo", "Ambroise Wonkam", "Denis Chopera"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["Michelle Skelton", "Dee Blackhurst", "Kevin Dzobo", "Ambroise Wonkam", "Denis Chopera"], "gold": [], "text": "Denis Chopera, Kevin Dzobo, Ambroise Wonkam, Dee Blackhurst and Michelle Skelton commented."}, {"generated": ["two simulation scenarios"], "gold": [], "text": "Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg \u00d7 4 times daily + GGT 7680 mg once daily) in a week."}, {"generated": ["Y.C.P."], "gold": [], "text": "and Y.C.P."}, {"generated": ["elderly subjects"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["patients taking prescription medications", "many individuals greater than 65 years of age"], "gold": [], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["patients taking prescription medications", "many individuals greater than 65 years of age"], "gold": [], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["All subjects"], "gold": [], "text": "[45] Go to: RESULTS General Experimental Observations  All subjects completed the study and no serious adverse events occurred during the course of the investigation."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation."}, {"generated": ["17th study", "single-time point phenotypic ratio approach"], "gold": [], "text": "[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John\u2019s wort when more conventional \u201carea-under-the-curve\u201d methods were utilized to determine midazolam clearance."}, {"generated": ["17th study", "single-time point phenotypic ratio approach"], "gold": [], "text": "[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John\u2019s wort when more conventional \u201carea-under-the-curve\u201d methods were utilized to determine midazolam clearance."}, {"generated": ["elderly patients"], "gold": [], "text": "[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy."}, {"generated": ["18"], "gold": [], "text": "[18] Taken together these findings indicate that herb-drug interactions attributable to G. biloba are not the result of phytochemical-mediated effects on CYP isoforms."}, {"generated": ["participants"], "gold": [], "text": "Participants were certified healthy by a physician based on medical history, clinical examination, and laboratory tests and they gave their written informed consent to comply with the study protocol."}, {"generated": ["12 participants", "Venous blood samples"], "gold": [], "text": "Sample collection  Venous blood samples (5ml) was collected into heparinised tubes at time zero (just before the administration of quinine sulphate tablets)) and at 1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h after each participant received quinine alone or concurrently with the scheduled dose of G. kola."}, {"generated": ["12 participants", "Venous blood samples"], "gold": [], "text": "Sample collection  Venous blood samples (5ml) was collected into heparinised tubes at time zero (just before the administration of quinine sulphate tablets)) and at 1, 2, 3,4, 6, 8, 12, 24, 36 and 48 h after each participant received quinine alone or concurrently with the scheduled dose of G. kola."}, {"generated": ["77 additional participants"], "gold": [], "text": "In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo."}, {"generated": ["More than 50% of adults in KwaZulu-Natal"], "gold": [], "text": "More than 50% of adults in KwaZulu-Natal attending public sector facilities for ART initiation disclose using TCAM [10], and similar levels of TCAM use by HIV positive individuals may occur worldwide [11]."}, {"generated": ["serial electrocardiograms"], "gold": [], "text": "On serial electrocardiograms the PR interval, QRS duration and corrected QT interval (QTc) were similar in both arms (S2 Table)."}, {"generated": ["a large number of therapies"], "gold": [], "text": "However, a large number of these therapies have been shown that they are not safe and can be harmful due to their interactions with other drugs which are used contemporaneously."}, {"generated": ["patients' demographic information"], "gold": [], "text": "After obtaining institutional ethics committee approval (project number and ethics code: 294155) from the university research affairs, patients' demographic information (sex, age, educational status, occupational status, and marital status) were collected from patients' hospital records or by direct interviewing of patients and filled in a specially designed form for this study."}, {"generated": ["20\u201360 years", "male/female ratio of 73/27 percent", "majority"], "gold": [], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["20\u201360 years", "male/female ratio of 73/27 percent", "majority"], "gold": [], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["20\u201360 years", "male/female ratio of 73/27 percent", "majority"], "gold": [], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["13.23%"], "gold": [], "text": "The others (13.23%) consisted of congenital kidney disease, polycystic kidney disease, drug-induced renal failure, and acute kidney injury."}, {"generated": ["patient"], "gold": [], "text": "The patient had a Karnofsky performance status scale of 90% after resection without neurological deficiencies and was referred to our department for further treatment with radiotherapy and temozolomide (TEM)."}, {"generated": ["18 F"], "gold": [], "text": "Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy."}, {"generated": ["Twelve adult male Sprague Dawley rats (approximately 3 months old)"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["(2007)"], "gold": [], "text": "(2007) also investigated the effect of pretreatment with cranberry juice for 5 days on warfarin pharmacokinetics and found no clinically significant change in the AUC of S-warfarin."}, {"generated": ["7 patients with atrial fibrillation"], "gold": ["7 patients"], "text": "(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al."}, {"generated": ["(2007)"], "gold": [], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["Patients"], "gold": [], "text": "Current address: Drug Metabolism and Pharmacokinetics, Covance Laboratories Inc., Madison, WI, USA Patients commonly take complementary medicines in conjunction with warfarin yet evidence supporting the safety or the risk of a herb\u2013drug interaction is lacking."}, {"generated": ["recent popular publications", "widely used information websites"], "gold": [], "text": "Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs."}, {"generated": ["recent popular publications", "widely used information websites"], "gold": [], "text": "Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs."}, {"generated": ["36"], "gold": [], "text": "[36]."}, {"generated": ["participants"], "gold": [], "text": "Daily before going to bed, participants took two tablets, with 500\u2009mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51\u2009mg/tablet), for 14 subsequent days."}, {"generated": ["Before and after the test period", "CYP 1A2", "CYP 3A4/5", "CYP 2E1", "CYP 2D6"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["Before and after the test period", "CYP 1A2", "CYP 3A4/5", "CYP 2E1", "CYP 2D6"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["Before and after the test period", "CYP 1A2", "CYP 3A4/5", "CYP 2E1", "CYP 2D6"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["Before and after the test period", "CYP 1A2", "CYP 3A4/5", "CYP 2E1", "CYP 2D6"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["Before and after the test period", "CYP 1A2", "CYP 3A4/5", "CYP 2E1", "CYP 2D6"], "gold": [], "text": "Before and after the test period, the activities of CYP 3A4/5 (1-hydroxymidazolam/midazolam serum ratio), CYP 1A2 (paraxanthine/caffeine serum ratio), CYP 2E1 (hydroxychlorzoxazone/chlorzoxazone serum ratio), and CYP 2D6 (debrisoquine urinary recovery ratio) were determined."}, {"generated": ["two case reports"], "gold": [], "text": "A possible pharmacodynamic interaction of valerian preparations with other drugs is supported only by two case reports."}, {"generated": ["relevant risk"], "gold": [], "text": "At present therefore a relevant risk of pharmacodynamic interactions is not proven by valid clinical observations."}, {"generated": ["warnings", "specific risk of interactions of valerian"], "gold": [], "text": "In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence."}, {"generated": ["warnings", "specific risk of interactions of valerian"], "gold": [], "text": "In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence."}, {"generated": ["After venlafaxine discontinuation"], "gold": [], "text": "After venlafaxine discontinuation, there was rapid improvement, with regression of the radiological abnormalities and normalization of the LVEF."}, {"generated": ["Uma investiga\u00e7\u00e3o ampla"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6", "administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6", "administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["maioria dos medicamentos card\u00edacos"], "gold": [], "text": "A maioria dos medicamentos card\u00edacos foi, portanto, descontinuada."}, {"generated": ["35-year-old patient"], "gold": [], "text": "O caso ocorreu em uma paciente previamente h\u00edgida de 35 anos de idade que foi submetida a investiga\u00e7\u00e3o exaustiva ap\u00f3s a exclus\u00e3o de outras poss\u00edveis causas."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["one subject with pruritus and hot flash", "one subject with headache"], "gold": [], "text": "In addition, one subject with pruritus and hot flash and another subject with headache fully recovered after discontinuation of administration in the placebo group."}, {"generated": ["one subject with pruritus and hot flash", "one subject with headache"], "gold": [], "text": "In addition, one subject with pruritus and hot flash and another subject with headache fully recovered after discontinuation of administration in the placebo group."}, {"generated": ["large-scale menopausal subjects"], "gold": [], "text": "However, further research is needed on the safety of RHC intake for a long period in large-scale menopausal subjects."}, {"generated": ["Korean red ginseng extract", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["Korean red ginseng extract", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["repeated administration of RGE", "high dose of Rc"], "gold": [], "text": "The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb\u2013drug interactions involving valsartan (Figure 5 and Figure 8)."}, {"generated": ["repeated administration of RGE", "high dose of Rc"], "gold": [], "text": "The results revealed that the repeated administration of RGE and high dose of Rc did not significantly induce herb\u2013drug interactions involving valsartan (Figure 5 and Figure 8)."}, {"generated": ["rat liver", "plasma concentration", "rat plasma"], "gold": [], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["rat liver", "plasma concentration", "rat plasma"], "gold": [], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["rat liver", "plasma concentration", "rat plasma"], "gold": [], "text": "The plasma concentration was ranged from 7.8 \u03bcM to 34.1 \u03bcM but unbound fraction of tri-glycosylated PPD-type ginsenosides (Rb1, Rb2, and Rc) was very low (0.1\u20130.2% in rat plasma, 0.4\u20130.5% in rat liver; Figure 9B)."}, {"generated": ["blood samples", "plasma samples"], "gold": [], "text": "After centrifugation of the blood samples at 16,000\u00d7 g for 10 min, aliquots (50 \u03bcL each) of plasma samples were stored at \u221280 \u00b0C until the analysis of ginsenosides and valsartan."}, {"generated": ["blood samples", "plasma samples"], "gold": [], "text": "After centrifugation of the blood samples at 16,000\u00d7 g for 10 min, aliquots (50 \u03bcL each) of plasma samples were stored at \u221280 \u00b0C until the analysis of ginsenosides and valsartan."}, {"generated": ["rats", "AUC: area under the plasma concentration-time curve from 0 to 48 h"], "gold": [], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["rats", "AUC: area under the plasma concentration-time curve from 0 to 48 h"], "gold": [], "text": "AUC: area under the plasma concentration-time curve from 0 to 48 h C Pharmacokinetic parameters of valsartan and Rc following intravenous injection of valsartan at a dose of 1 mg/kg in rats."}, {"generated": ["herbal products"], "gold": [], "text": "Therefore, herbal products must be assessed for their efficacy and safety, including their potential for interactions with other drugs [14]."}, {"generated": ["herbal agent"], "gold": [], "text": "Therefore, use of an herbal agent with antioxidant and polyphenolic properties without significant side effects helps to treat PCOS as a disease of antioxidant deficiency [13]."}, {"generated": ["C. sinensis"], "gold": [], "text": "Moreover, hesperidin in C. sinensis increases the levels of antioxidants including SOD and CAT, and decreases the MDA level [19]."}, {"generated": ["One mL of methanolic extract", "120 g herbal mixture powder", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["One mL of methanolic extract", "120 g herbal mixture powder", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["One mL of methanolic extract", "120 g herbal mixture powder", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["Polymethoxylated flavones (PMFs)"], "gold": [], "text": "Polymethoxylated flavones (PMFs) of C. sinensis have hypolipidemic effects, resulting in a significant reduction of insulin tolerance and glucose levels [61]."}, {"generated": ["darunavir-ritonavir"], "gold": [], "text": "Thus, at the approved dosage of darunavir-ritonavir, darunavir concentrations at the end of the dosing interval remain well above the concentration needed to inhibit replication of HIV strains (20; V. Sekar, S. Spinosa-Guzman, E. Lefebvre, and R. Hoetelmans, presented at the 16th International AIDS Conference, 2006)."}, {"generated": ["median CD4+ T-cell count"], "gold": [], "text": "The median CD4+ T-cell count was 498 (range, 244 to 962) cells/mm3."}, {"generated": ["No patient"], "gold": [], "text": "No patient reported adverse events during the study, and all maintained an HIV-1 RNA load of <50 copies/ml at the end of the study."}, {"generated": ["darunavir"], "gold": [], "text": "Coadministration of E. purpurea resulted in little change in darunavir pharmacokinetic parameters, with C\u03c4 and AUC\u03c4 decreasing by averages of 16% and 10%, respectively."}, {"generated": ["this cohort"], "gold": [], "text": "The variability in the effect of echinacea on darunavir pharmacokinetics we observed in this cohort may imply some degree of uncertainty in the CYP3A4 inductive/inhibitory potential of this herbal remedy."}, {"generated": ["EGb 761\u00ae"], "gold": [], "text": "EGb 761\u00ae has no relevant effect on the in vivo activity of the major CYP enzymes in humans and therefore has no relevant potential to cause respective metabolic drug\u2013drug interactions."}, {"generated": ["240-mg EGb 761\u00ae daily dose"], "gold": [], "text": "A maximum exposure was realized with a 240-mg EGb 761\u00ae daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761\u00ae components was reached, and 1\u00a0week is typically sufficient to achieve full induction [35]."}, {"generated": ["two reviewers"], "gold": [], "text": "The study selection and data extraction used standard eligibility inclusion criteria as determined by two reviewers."}, {"generated": ["relevant case reports"], "gold": [], "text": "These relevant case reports indicated a potential herb-warfarin interaction, but it was difficult to identify a causal relationship."}, {"generated": ["she"], "gold": [], "text": "At the time of admission to ED, she had a prothrombin time (PT) of more than 37 seconds, activated partial thromboplastin time (aPTT) more than 70 seconds, and international normalized ratio (INR) greater than seven."}, {"generated": ["patient presenting with coagulopathy of unknown origin"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["SAS Institute"], "gold": [], "text": "The terminal elimination rate constant (\u03bb All statistical analyses were conducted using SAS (v. 9.2; SAS Institute)."}, {"generated": ["Cochrane Database of Systematic Reviews (2005\u2013December 2012)"], "gold": [], "text": "2012), Cochrane Database of Systematic Reviews (2005\u2013Dec."}, {"generated": ["2012"], "gold": [], "text": "2012)."}, {"generated": ["human"], "gold": [], "text": "Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63\u201365]."}, {"generated": ["patients with major depression or bipolar disorder"], "gold": [], "text": "In a randomized double-blinded control trial, Xiao-yao-san increased the incidence of CBZ-related side effects including dizziness, blurred vision, skin rash, and nausea in patients with major depression or bipolar disorder."}, {"generated": ["50% of the informants"], "gold": [], "text": "Fifty percent of the informants used herbal medicines alongside their prescription drugs."}, {"generated": ["patients'"], "gold": [], "text": "Tabular summary of the pharmacological management of the patients' based on their prescribed hypoglycaemic agents."}, {"generated": ["12 identified plants"], "gold": [], "text": "For all of the 12 identified plants, pharmacological evidence validating their traditional use in diabetes management have been published."}, {"generated": ["HepaRG cell line"], "gold": [], "text": "HepaRG cell line, derived from a hepatocellular carcinoma, could express a large panel of liver-specific enzymes [5,6,7]."}, {"generated": ["notoginsenoside R"], "gold": [], "text": "PNS contents were determined as: notoginsenoside R UPLC-MS/MS analysis was conducted on an Ultimate 3000 UPLC system (Thermo Fisher Scientific, Waltham, MA, USA) equipped with an LTQ-Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA)."}, {"generated": ["2 \u00d7 10 Total RNA"], "gold": [], "text": "Briefly, 2 \u00d7 10 Total RNA was extracted from the cells using the Trizol (CW0581, CWbio, Beijing, China)."}, {"generated": ["Samento"], "gold": [], "text": "To demonstrate possible influences on aryl hydrocarbon receptor (AhR), another important transcription factor regulating e.g., CYP1A, we also tested whether Samento can activate AhR and found only a minor effect compared to the positive control omeprazole (Figure 4B)."}, {"generated": ["herbal preparations", "PXR activating drugs"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["herbal preparations", "PXR activating drugs"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["T. R\u00fctzert", "D. Ballinari", "A. Fautsch", "S. Rosenzweig", "C. Mueller", "D. Keppler", "D. Theile", "A. H. Schinkel", "J. Kocher"], "gold": [], "text": "Thanks to J. Kocher, S. Rosenzweig, C. Mueller, A. Fautsch, and T. R\u00fctzert for excellent technical assistance, to D. Ballinari (Pharmacia & Upjohn, Milano, Italy) for providing P388 and P388/dx cells, to A. H. Schinkel (The Netherlands Cancer Institute, Amsterdam, The Netherlands) for providing MDCKII-BCRP cells, to D. Keppler (German Cancer Research Centre, Heidelberg, Germany) for providing HEK-OATP1B1 and HEK-OATP1B3 cell lines, to Z. Dvorak (Palyck\u00fd University, Olomouc, Czech Republic) for providing the AZ-AhR cells, and to D. Theile for careful proofreading of the manuscript."}, {"generated": ["Korean Pharmaceutical Codex"], "gold": [], "text": "It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1]."}, {"generated": ["pomegranate", "grapefruit"], "gold": [], "text": "The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types."}, {"generated": ["pomegranate", "grapefruit"], "gold": [], "text": "The herbal reaction toward different types of statins is varied so that grapefruit or pomegranate was interacted with only some types of statins, but not with all statin types."}, {"generated": ["Group IV"], "gold": [], "text": "on the 7th day, 2\u2009h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days."}, {"generated": ["M.A.A."], "gold": [], "text": "and M.A.A."}, {"generated": ["rats"], "gold": [], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["this population"], "gold": [], "text": "If so, herb-mediated changes in CYP activity may take on greater clinical relevance in this population."}, {"generated": ["subjects", "5 isokinetic knee extensions", "2 min"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["subjects", "5 isokinetic knee extensions", "2 min"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["subjects", "5 isokinetic knee extensions", "2 min"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["subject\u2019s knee joint center"], "gold": [], "text": "The subject\u2019s knee joint center, measured using the femoral epicondyles as a joint center reference, was aligned with the axis of the isokinetic dynamometer."}, {"generated": ["no significant differences"], "gold": [], "text": "There were no significant differences between the groups for height, weight, or BMI at baseline (Table 1)."}, {"generated": ["have shown"], "gold": [], "text": "have shown the association between high lactate production and reduced oxidative metabolism [47]."}, {"generated": ["first clinically relevant reports"], "gold": [], "text": "The first clinically relevant reports of preparations of St. John's wort (SJW), a herbal medicine with anti\u2010depressant effects, interacting with other drugs, altering their bioavailability and efficacy, were published about 20 years ago."}, {"generated": ["several investigators", "SJW extracts"], "gold": [], "text": "The tail suspension test, which also measures changes in immobility in rodents after antidepressant treatment, was applied by several investigators (Butterweck, Christoffel, et al., 2003; Machado et al., 2008; Tian et al., 2014) and SJW extracts significantly reduced the time of immobility in this test."}, {"generated": ["several investigators", "SJW extracts"], "gold": [], "text": "The tail suspension test, which also measures changes in immobility in rodents after antidepressant treatment, was applied by several investigators (Butterweck, Christoffel, et al., 2003; Machado et al., 2008; Tian et al., 2014) and SJW extracts significantly reduced the time of immobility in this test."}, {"generated": ["seven test drugs"], "gold": [], "text": "This statement was provided even before another comprehensive pharmacokinetic interaction study was published, where no clinically relevant interactions were found for seven test drugs in concomitant application with a low\u2010hyperforin SJW extract (Zahner et al., 2019)."}, {"generated": ["Yunzhi\u2013drug combinations"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["recent study"], "gold": [], "text": "Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97]."}, {"generated": ["150\u2013250 g", "12 adult male rats", "approximately 3 months old", "Sprague Dawley rats"], "gold": [], "text": "a."}, {"generated": ["150\u2013250 g", "12 adult male rats", "approximately 3 months old", "Sprague Dawley rats"], "gold": [], "text": "a."}, {"generated": ["150\u2013250 g", "12 adult male rats", "approximately 3 months old", "Sprague Dawley rats"], "gold": [], "text": "a."}, {"generated": ["150\u2013250 g", "12 adult male rats", "approximately 3 months old", "Sprague Dawley rats"], "gold": [], "text": "a."}, {"generated": ["medicinal mushrooms"], "gold": [], "text": "In summary, the aforementioned outcomes suggest that medicinal mushrooms have great potential to ameliorate the adverse effects of chemotherapeutic drugs in clinical settings."}, {"generated": ["Women diagnosed with breast cancer"], "gold": [], "text": "Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy."}, {"generated": ["approximately 70\u201380% of all breast tumors"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["Clinical studies"], "gold": [], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["Pooled human liver microsomes (HLMs, 50 donors, mixed gender)"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["studies"], "gold": [], "text": "The metabolic activity of CYP2D6 was suggested to be associated with the long-term outcomes in breast cancer, although the studies are inconsistent [35]."}, {"generated": ["50 donors"], "gold": [], "text": "The significant inter-individual variability of CYP2D6 activity due to genetic polymorphisms was mitigated by the use of pooled microsomes from 50 donors [41]."}, {"generated": ["Springer Nature"], "gold": [], "text": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, {"generated": ["Two weeks of coadministration"], "gold": [], "text": "Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter."}, {"generated": ["2016"], "gold": [], "text": "2016)."}, {"generated": ["laboratory rodent chow"], "gold": [], "text": "Water and food (laboratory rodent chow, Shanghai, China) were allowed ad libitum."}, {"generated": ["six subjects"], "gold": [], "text": "(n\u00a0=\u00a06)."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["H.O.", "T.O.", "Y.O.", "S.M.", "K.S.", "E.H.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., E.H., T.O., H.O., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["Y.O.", "S.M.", "H.W.", "J.K.", "M.F.", "K.S.", "R.T."], "gold": [], "text": "S.M., Y.O., R.T., J.K., H.W., M.F., and K.S."}, {"generated": ["low levels of SITA"], "gold": [], "text": "Despite low levels of SITA, the combination demonstrated a significant reduction in blood glucose level when compared with individual drug and individual extract administered groups during pharmacodynamic study."}, {"generated": ["one of the probable concomitant treatments"], "gold": [], "text": "The present work was carried out to check the safety and efficacy of one of the probable concomitant treatments that a diabetic patient is likely to undertake during the course of his treatment."}, {"generated": ["12 adult male Sprague Dawley rats"], "gold": [], "text": "3a and b)."}, {"generated": ["significantly different from normal group", "significantly different from diabetic control group"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["significantly different from normal group", "significantly different from diabetic control group"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["Treatment with EJE\u202f+\u202fSITA", "Treatment with EJE"], "gold": [], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["Treatment with EJE\u202f+\u202fSITA", "Treatment with EJE"], "gold": [], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["9"], "gold": [], "text": "9, Table\u00a02)."}, {"generated": ["significantly different from normal group", "significantly different from diabetic control group"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["significantly different from normal group", "significantly different from diabetic control group"], "gold": [], "text": "*significantly different from normal group, # significantly different from diabetic control group at p\u00a0<\u00a00.001."}, {"generated": ["patient"], "gold": [], "text": "The patient was compliant regarding the attendance of appointments and in taking the medication, and maintained a therapeutic INR (1.7\u20132.5) on a maintenance daily dose of 1.875 mg warfarin with monthly INR monitoring."}, {"generated": ["7 subjects"], "gold": [], "text": "[7] previously showed that administration of 375 ml wine did not result in thrombin times (TTs) outside the therapeutic range, which suggested that a moderate intake of alcohol occasionally may be acceptable during anticoagulant therapy."}, {"generated": ["Gouqizi"], "gold": [], "text": "In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement."}, {"generated": ["patients with atrial fibrillation"], "gold": [], "text": "Due to public concern regarding the risk of bleeding during treatment with warfarin, as well as the uneasy relationship between allopathic doctors and their patients, no more than 10% of patients with atrial fibrillation take warfarin in China [5]."}, {"generated": ["three patients"], "gold": [], "text": "However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin."}, {"generated": ["Animal studies"], "gold": [], "text": "Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner."}, {"generated": ["HS varieties with deeper red calyxes"], "gold": [], "text": "The HS varieties with deeper red calyxes exhibited greater antioxidant activity as compared to lighter red or white varieties [44, 45]."}, {"generated": ["Cholesterol RCT interventions"], "gold": [], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": ["hypertensive patients"], "gold": [], "text": "One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18]."}, {"generated": ["customers"], "gold": [], "text": "As a service to our customers we are providing this early version of the manuscript."}, {"generated": ["21"], "gold": [], "text": "21 Clearly, a reliable and systematic approach to predict these herb\u2013drug interactions is needed."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "Go to: 2."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "2.1.2."}, {"generated": ["three lignans"], "gold": [], "text": "Prediction differences of pharmacokinetic parameters for the three lignans, expressed as the ratio of PBPK model prediction to clinically\u2010reported parameter values were also evaluated."}, {"generated": ["72 subjects"], "gold": [], "text": "by carbamazepine and phenytoin, 72 the predominant outcome from a chronic exposure to Schisandra lignans is a CYP3A inhibition and not induction."}, {"generated": ["S. sphenanthera extract"], "gold": [], "text": "Constituents of S. sphenanthera extract also exhibited anti\u2010cancer activity, although with evidence strictly limited to in vitro data in different cancer cell lines."}, {"generated": ["Sixty Sprague\u2013Dawley rats"], "gold": [], "text": "Sixty Sprague\u2013Dawley rats were used to investigate the effects of warfarin (0.2\u00a0mg/kg), Danshen (240 or 480\u00a0mg/kg) and Gegen (240 or 480\u00a0mg/kg) both in isolation and combination."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["Racemic warfarin", "diclofenac sodium", "naringin"], "gold": [], "text": "The plant names in current study were used according to the latest revision in \u201cThe Plant List\u201d ( Racemic warfarin, diclofenac sodium and naringin (internal standards) were purchased from Sigma-Aldrich (St. Louis, MO, USA)."}, {"generated": ["rats"], "gold": [], "text": "The results of our previous study showed that the administration of a DFG-warfarin combination led to a reduction in the warfarin plasma concentration and PT time of rats [23, 32]."}, {"generated": ["several case reports"], "gold": [], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["Li et al."], "gold": [], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["48 women"], "gold": [], "text": "The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37\u2009months (range 4\u2013113) from completion of chemotherapy."}, {"generated": ["12 adult male Sprague Dawley rats"], "gold": [], "text": "Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb\u2013drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not\u2010for\u2010profit sectors Management of chronic diseases is burdensome to patients (Eton et\u00a0al., 2013; \u00d8rtenblad, Meillier, & J\u00f8nsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et\u00a0al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self\u2010medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008)."}, {"generated": ["Alstonia boonei", "Picralima nitida", "Bauhinia monandra"], "gold": [], "text": "Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub\u2010Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014)."}, {"generated": ["Alstonia boonei", "Picralima nitida", "Bauhinia monandra"], "gold": [], "text": "Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub\u2010Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014)."}, {"generated": ["Alstonia boonei", "Picralima nitida", "Bauhinia monandra"], "gold": [], "text": "Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub\u2010Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014)."}, {"generated": ["most tropical medicinal herbs"], "gold": [], "text": "Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes."}, {"generated": ["Positive controls", "CYP isoenzymes"], "gold": [], "text": "Positive controls (see Supporting Information data, Table S1), CYP isoenzymes inhibited, and concentration used in the N\u2010in\u2010one assay are as reported in the validated methods (Turpeinen et\u00a0al., 2005; Tolonen et\u00a0al., 2007; Showande et\u00a0al., 2013)."}, {"generated": ["Positive controls", "CYP isoenzymes"], "gold": [], "text": "Positive controls (see Supporting Information data, Table S1), CYP isoenzymes inhibited, and concentration used in the N\u2010in\u2010one assay are as reported in the validated methods (Turpeinen et\u00a0al., 2005; Tolonen et\u00a0al., 2007; Showande et\u00a0al., 2013)."}, {"generated": ["commonly used herbs"], "gold": [], "text": "In vitro herb\u2013drug interactions studies are mostly conducted for commonly used herbs to evaluate and predict potentially significant in vivo herb\u2013drug interactions and to help design appropriate in vivo herb\u2013drug interaction studies (Fasinu, Bouic, & Rosenkranz, 2012; Awortwe, Bouic, Masimirembwa, & Rosenkranz, 2013)."}, {"generated": ["Three plants"], "gold": [], "text": "Three of the plants studied did not exhibit inhibitory potential on any of the eight major human CYP isoenzymes used even at the highest dose of the extract, that is, aqueous extracts of Musa sapientum unripe fruits, Tetracarpidium conophorum seeds, and Allium sativum bulbs."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "(2000)."}, {"generated": ["Alstonia boonei", "Gongronema latifolium"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["Alstonia boonei", "Gongronema latifolium"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["patented polyherbal formulation"], "gold": [], "text": "Ltd., Varanasi, India) is a patented polyherbal formulation developed to manage menopause symptoms that can be taken along with other allopathic medicines."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "34860-2.5L-R) and ammonium acetate (catalog No."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No."}, {"generated": ["herbal medicines"], "gold": [], "text": "Herb-drug interactions incidence was predicted to increase due to herbal medicines' worldwide popularity with the development of several herbal formulations with improved bioavailability."}, {"generated": ["65-year-old man"], "gold": [], "text": "Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic\u00ae Software Abel Saldarreaga Marin, 1 Marc Cendros, 2 Carlos J Ciudad, 3 and Ana Sabater 2 Author information Article notes Copyright and License information PMC Disclaimer Go to: Abstract  This was a case report of severe fatigue and bleeding in a 65-year-old man with ischemic heart disease who was wearing a stent and taking multiple medications for hypertension and diabetes."}, {"generated": ["health care professionals", "Jamaican prescription drug users", "cancer patients"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["health care professionals", "Jamaican prescription drug users", "cancer patients"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["health care professionals", "Jamaican prescription drug users", "cancer patients"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["Department of Chemistry, University of the West Indies, Mona Campus, Jamaica", "five lignans", "\u03b2-Sitosterol", "cadina-4,10(15)-dien-3-one"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["Department of Chemistry, University of the West Indies, Mona Campus, Jamaica", "five lignans", "\u03b2-Sitosterol", "cadina-4,10(15)-dien-3-one"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["Department of Chemistry, University of the West Indies, Mona Campus, Jamaica", "five lignans", "\u03b2-Sitosterol", "cadina-4,10(15)-dien-3-one"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["Department of Chemistry, University of the West Indies, Mona Campus, Jamaica", "five lignans", "\u03b2-Sitosterol", "cadina-4,10(15)-dien-3-one"], "gold": [], "text": "\u03b2-Sitosterol, cadina-4,10(15)-dien-3-one and a mix of five lignans comprised of dehydropodophyllotoxin, deoxydehydropodophyllotoxin, 4\u2032-demethyldesoxypodophyllotoxin, 5\u2032-methoxydehydropodophyllotoxin, and dehydro-b-peltatin methyl ether were supplied by the Department of Chemistry, University of the West Indies, Mona Campus, Jamaica."}, {"generated": ["15 natural products"], "gold": [], "text": "[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6."}, {"generated": ["12 adult male Sprague Dawley rats"], "gold": [], "text": "[35]."}, {"generated": ["Five days"], "gold": [], "text": "Five days after presentation, her symptoms had completely resolved."}, {"generated": ["10 mL of blood"], "gold": [], "text": "At 30\u202fmin following the 8PM dose on Day 5, the rats were anesthetized and about 10\u202fmL of blood were collected from rats\u2019 inferior vena for determination of antiviral activity."}, {"generated": ["ten marker components"], "gold": [], "text": "Results from RLM and hCE1 showed a similar trend for the ten marker components (Figs."}, {"generated": ["in-vitro experiments"], "gold": [], "text": "S4, the P The above in-vitro experiments suggested that there should be some potential HDI between OS and these anti-influenza herbs/herbal components during absorption and metabolism."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "The results suggested that co-administration with RS could significantly increase the systemic exposure of OS and decrease that of OSA (Fig."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "This can further be verified by the lowered OSA/OS ratio in rat urine samples after co-administration with RS (Fig."}, {"generated": ["S8"], "gold": [], "text": "S8)."}, {"generated": ["enzymes", "cells", "influenza viruses", "microsomes"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["enzymes", "cells", "influenza viruses", "microsomes"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["enzymes", "cells", "influenza viruses", "microsomes"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["enzymes", "cells", "influenza viruses", "microsomes"], "gold": [], "text": "In our current study, a screening platform based on microsomes, enzymes, cells and influenza viruses have for the first time been developed and utilized to screen potential interaction between OS and anti-influenza herb/herbal components."}, {"generated": ["Table 1", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": ["Table 1", "Twelve adult male Sprague Dawley rats"], "gold": [], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": ["Fructus Arctii"], "gold": [], "text": "Fructus Arctii (Fruit of Arctium lappa L., Niubangzi)."}, {"generated": ["30%\u201370% of clinical breast cancer patients"], "gold": [], "text": "30%\u201370% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions."}, {"generated": ["cancer patients", "breast cancer patients"], "gold": [], "text": "Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010)."}, {"generated": ["cancer patients", "breast cancer patients"], "gold": [], "text": "Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010)."}, {"generated": ["150\u2013250 g", "Twelve adult male Sprague Dawley rats (approximately 3 months old)"], "gold": [], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["150\u2013250 g", "Twelve adult male Sprague Dawley rats (approximately 3 months old)"], "gold": [], "text": "), dried orange peel (Citrus aurantium L.), Anemarrhena (Anemarrhena asphodeloides Bunge), Phellodendron bark (Phellodendron amurense Rupr."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "), Licorice (Glycyrrhiza glabra L.), Ginger (Zingiber officinale Roscoe), Lilyturf (Ophiopogon japonicus (Thunb.)"}, {"generated": ["TAM-intoxicated liver injury in rats"], "gold": [], "text": "DDB is found to alleviate the oxidative stress status of TAM-intoxicated liver injury in rats, with the study reporting a significant increase in antioxidant enzymes, a significant decrease in the activity of sGPT and sGOT, reduction of glutathione concomitant, and a significant reduction of TBARS and liver transaminases (El-Beshbishy, 2005b)."}, {"generated": ["communicable diseases"], "gold": [], "text": "Communicable diseases are still leading causes of death and disability globally, according to WHO\u2019s Global Health Estimates 2000\u20132019 (GBD Diseases and Injuries, 2020)."}, {"generated": ["rats"], "gold": [], "text": "PCE significantly increased the tissue to plasma distribution coefficients (K  Tissue distribution profiles of ciprofloxacin (CIP) after intravenous administration of CIP in the absence (A) and presence (B) of PCE to rats, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of GA in normal rats after intragastric administration of PCE in the absence and presence of CIP are displayed in Figures 7A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Twelve adult Sprague Dawley rats", "PCA", "Ciprofloxacin", "CIP", "PCE", "Gallic acid (GA)"], "gold": [], "text": "CIP significantly increased the K  Tissue distribution profiles of gallic acid (GA) after oral administration of PCE in the absence (A) and presence (B) of ciprofloxacin, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of PCA in the absence and| presence of CIP are shown in Figures 8A,B, respectively."}, {"generated": ["Vance-Bryan et al., 1990"], "gold": [], "text": "Since the liver metabolism (approximately 10%) and biliary excretion (approximately 1%) of the drug is relatively low (Vance-Bryan et al., 1990), the reduced circulating CIP in humans was mainly attributed to the change of CIP across the renal and intestinal epithelia."}, {"generated": ["previous studies", "healthy obese participants"], "gold": [], "text": "Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21]."}, {"generated": ["previous studies", "healthy obese participants"], "gold": [], "text": "Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["quinic acid", "triterpenic saponins", "mono-caffeolquinic acids", "minerals", "chlorogenic acids", "di-caffeolquinic acids", "hydroxycinnamic acids", "vitamins", "caffeic acid"], "gold": [], "text": "The metabolic effects include adrengenic effects and stimulated central nervous system associated with caffeine, anti-lipolytic, and hypocholesterolemic properties in chlorogenic acids (mono- and di-caffeolquinic acids) hydroxycinnamic acids (caffeic acid, quinic acid) and triterpenic saponins, and other minerals and vitamins [5]."}, {"generated": ["all females who took part"], "gold": [], "text": "The BF% data indicated all females who took part were at the lower BF% percentile, indicating that they were physically active, with higher  Although the positive effects of YM on fat-loss outcomes during exercise are found only in single trials, future research could test the longitudinal YM effectiveness, especially when combining regular exercise training with YM treatment."}, {"generated": ["HEK293 cells"], "gold": [], "text": "[ HEK293 cells transiently overexpressing OAT1, OAT3, OCT1, OCT2, OATP1B1, and OATP1B3 transporters were purchased from Corning-Gentest (Tewksbury, MA, USA)."}, {"generated": ["respondents"], "gold": [], "text": "showed that the practice of herbal co-medication with prescription drugs cut across various patient demographics, with 38% of respondents reporting concomitant herbal use [6]."}, {"generated": ["grapefruit juice"], "gold": [], "text": "Since the accidental discovery of the ability of grapefruit juice to alter the pharmacokinetic profiles of felodipine through the inhibition of cytochrome P450 (CYP) and P-glycoprotein (P-gp), more studies have elucidated various mechanisms of HDI [11]."}, {"generated": ["Anecdotal evidence"], "gold": [], "text": "Anecdotal pieces of evidence like this not only highlight the reality and severity of the consequences of HDIs, they underscore the importance of further studies to guide clinical decisions."}, {"generated": ["Several controlled clinical studies"], "gold": [], "text": "Several controlled clinical studies, as shown by review and meta-analysis of published data, suggest that the use of ginkgo is associated with clinically significant improvement in symptoms of cognition decline and memory loss, anxiety and mood disorders, fatigue and general well-being, as well as cardiovascular disorders [59-61]."}, {"generated": ["He"], "gold": [], "text": "He was reported to have experienced a seizure before his death, and the toxicological autopsy results revealed subtherapeutic serum levels for both drugs."}, {"generated": ["Chronic use of ginseng"], "gold": [], "text": "Chronic use of ginseng on its own has been associated with manic psychosis [90]."}, {"generated": ["many marketed herbal products"], "gold": [], "text": "This is because many marketed herbal products are made of mixtures of different herbal species and/or dietary supplements whose biological disposition in humans is poorly understood."}, {"generated": ["serum creatinine level"], "gold": [], "text": "At that time the serum creatinine level was 74.27\u2009\u00b5mol/L and was stable."}, {"generated": ["serum creatinine level"], "gold": [], "text": "At that time the serum creatinine level was 74.27\u2009\u00b5mol/L and was stable."}, {"generated": ["Twelve adult male Sprague Dawley rats"], "gold": [], "text": "et Zucc.)"}, {"generated": ["two studies"], "gold": [], "text": "Thus, two studies from Canada and the USA were screened to find plants that patients might use."}, {"generated": ["Spanish study"], "gold": [], "text": "A Spanish study reports Aloe vera [37]."}, {"generated": ["patients who cannot reach pain relief otherwise"], "gold": [], "text": "Short-term use of opioids for patients who cannot reach pain relief otherwise may occur, e.g., to bridge the time until surgical intervention."}, {"generated": ["another patient"], "gold": [], "text": "Another patient experienced liver injury after taking 500 mg leaf powder every 2\u20133 days as a laxative [117]."}, {"generated": ["unknown"], "gold": [], "text": "This is debated, and there are hints to possible beneficial effects [135]."}, {"generated": ["Allium sativum"], "gold": ["European"], "text": "The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154]."}, {"generated": ["EFSA"], "gold": [], "text": "A scientific opinion of EFSA [196] from 2018 states that the common food consumption is safe, as there are only few cases of HILI associated with tea consumption despite the widespread use."}, {"generated": ["rats"], "gold": [], "text": "applied atorvastatin in rats after 3 weeks of drinking green tea or water."}, {"generated": ["HMP", "Valerian"], "gold": [], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["HMP", "Valerian"], "gold": [], "text": "Valerian, for example, is marketed in Germany, mainly as HMP, and, thus, possibly a great proportion of consumption was not included in the survey by Garcia-Alvarez [7]."}, {"generated": ["individuals with diabetes"], "gold": [], "text": "These findings suggest further research in individuals with diabetes is required to determine the effect of the combination of gymnema tea and metformin on blood sugar levels."}, {"generated": ["Lycium"], "gold": [], "text": "Findings such as these suggest that Lycium may have an additive effect when used in combination with conventional antidiabetics [86]."}, {"generated": ["Springer Nature"], "gold": [], "text": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, {"generated": ["healthy human volunteers"], "gold": [], "text": "The in vivo study was conducted on healthy human volunteers."}, {"generated": ["patient"], "gold": [], "text": "Moreover, the reckless pieces of information about possible effects of diet, such as fatigue and loose stools, elicited confusion in the patient."}], "FN": [{"generated": ["7 patients with atrial fibrillation"], "gold": ["7 patients"], "text": "(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al."}, {"generated": [], "gold": ["a total of 24 subjects"], "text": "In order to compensate for study participants who did not complete both treatment phases, a total of 24 subjects were to be randomised."}, {"generated": [], "gold": ["75 participants"], "text": "Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25)."}, {"generated": [], "gold": ["two children"], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": [], "gold": ["four groups (n = 6)"], "text": "All animals were retained in polypropylene cages: 6 animals were caged (n = 6) per cage with a 12-h light/dark cycle, at 25 \u00b0C in humane conditions with free access to food and water and adapted to the living conditions one week prior to experiment The animals were categorized into four groups (n = 6) and fasted for 12 h before the experiment."}, {"generated": ["Allium sativum"], "gold": ["European"], "text": "The European pharmacopoeia monographs pulverized dried bulbs of Allium sativum containing at least 0.45% allicin [154]."}]}